Jeremy Lewin
The University of Melbourne(AU)Peter MacCallum Cancer Centre(AU)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Testicular diseases and treatments, Childhood Cancer Survivors' Quality of Life, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors(2018)274 cited
- → PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial(2022)242 cited
- → Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial(2023)178 cited
- → Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC).(2016)158 cited
- → Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial(2021)135 cited
- → Facilitating a culture of responsible and effective sharing of cancer genome data(2016)92 cited
- → Long-term care for people treated for cancer during childhood and adolescence(2022)83 cited
- → Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis(2018)62 cited
- → Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma(2018)62 cited
- → The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options(2017)57 cited